Can gut markers show early if a UC treatment works?
Part of Digestive system clinical trials.
This study looks at stool samples to see if certain markers can quickly tell whether a biologic medicine is starting to work for moderate-to-severe ulcerative colitis. If successful, this could help doctors make faster, smarter treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with ulcerative colitis and currently have moderate-to-severe symptoms.
- You are about to start treatment with either vedolizumab or infliximab within 7 days.
- You have not used a biologic before, or you have only tried one type called a TNF-alpha inhibitor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether early stool tests (fecal immunochemical test and calprotectin) can predict when ulcerative colitis symptoms might return. It is for people who have never taken biologic medications.
This study looks at whether a simple stool test can tell if treatment is healing the gut lining in people with moderate to severe ulcerative colitis who are starting their first biologic medicine. If it works, this test might help doctors adjust treatment earlier.
This study tests whether monitoring ulcerative colitis with stool-based markers—simple, non-invasive tests—can help guide treatment as effectively as the usual care approach. It aims to see if this strategy helps you stay in remission and avoid flare-ups.
This study tests a new way to monitor ulcerative colitis using stool tests and colonoscopy to detect early signs of cancer. It may help doctors manage long-term ulcerative colitis more safely.
This study tests non-invasive tools to find active inflammation in people with Crohn's disease or ulcerative colitis. You may need to give extra stool samples before your colonoscopy and calprotectin test.
This trial tests three different types of biologic medications to find which works best as a first treatment for moderate-to-severe ulcerative colitis.
Hear when a new FIT trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.